Pholtex Mucus 200 200 mg Effervescent tablets
PDF Leaflet Revision Date: 4 October 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Mucolytic for non-infective secretions in cystic fibrosis and respiratory conditions.
Dosage (summary)
Adults: 200 mg three times daily; Children: Under 2 years: 200 mg once daily, 2-6 years: 200 mg twice daily.
Special Populations
- Asthmatic patients
- History of peptic ulceration
- Sorbitol intolerance
Pregnancy & Breastfeeding
Safety during pregnancy and lactation not established; not advised for breastfeeding women.
Contraindications
- Hypersensitivity to N-Acetylcysteine or ingredients
Common side effects
- Headache
- Drowsiness
- Nausea
- Vomiting
- Bronchospasm
Counselling Points
- Dissolve tablet in water before use
- Report any adverse reactions
Serious warnings
- Use with caution in asthmatic patients
- May disrupt gastric mucosal barrier
Important Disclaimer
The Pholtex Mucus 200 200 mg Effervescent tablets professional information leaflet below is the property of Inova Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
